Key Influencer in the Mesenchymal Stem Cells Market 2025: Regenerative Medicine Driving Growth in the Mesenchymal Stem Cell (MSC) Market Driver

What Is the Forecasted Market Size and Growth Rate for the Mesenchymal Stem Cells Market?_x000D_
Over the recent years, there has been a significant expansion in the market size of mesenchymal stem cells. The market is projected to escalate from $3.38 billion in 2024 to $3.82 billion in 2025, with a compound annual growth rate (CAGR) of 13.0%. Factors such as the shift towards regenerative medicine, joint research projects, heightened public comprehension and support for stem cell research, global cooperation, and standardization measures have contributed to the historical growth of this market._x000D_
_x000D_
Expect a considerable rise in the market size for mesenchymal stem cells in the following years, surging to $6.14 billion by 2029 with a compound annual growth rate (CAGR) of 12.6%. This market growth during the forecast period is backed by ongoing improvements in genetic engineering technologies, the incorporation of personalized medical practices, the integration of artificial intelligence (AI) and data analytics, progress in the field of biomaterials science and 3D bioprinting technologies, the creation of microfluidic devices and organ-on-a-chip models, then the application of the latest manufacturing technologies. Key trends for the forecast period consist of tissue engineering and bioprinting, gene editing, expansion of clinical applications, combination therapies, and extracellular vesicles (EVs) derived from MSC._x000D_
_x000D_
What Factors Are Fueling Growth in the Mesenchymal Stem Cells Market?_x000D_
The rise in understanding about regenerative medicine is anticipated to drive the growth of the mesenchymal stem cells (MSC) market. As an emerging interdisciplinary domain, regenerative medicine deals with the repair, replacement, or regeneration of cells, tissues, or organs to recuperate impaired functions caused by congenital defects, diseases, trauma, and aging. The expansion of regenerative medicine is stimulated by several crucial elements like increasing clinical trials, the surge in chronic and age-related conditions, and personalized medicine. Regenerative medicine derives substantial prospect from mesenchymal stem cells (MSCs) owing to their capacity to transform into different cell types, manage immune responses, and foster tissue repair and regeneration across various medical conditions. As per a report by the Alliance for Regenerative Medicine in August 2023, there were 2,760 cells, gene, and tissue-engineering therapeutic creators globally in the first quarter of 2023, witnessing an increase of 101% since 1,369 in the first quarter of 2022. Furthermore, as reported by the American Society of Gene & Cell Therapy (ASGCT) and Citeline in July 2023, there were 247 gene therapies in Phase II by the end of Q1 2023, shot up by 5% to reach 260 by the end of Q2. Thus, the heightened awareness about regenerative medicine is propelling the growth of the mesenchymal stem cell (MSC) market._x000D_
_x000D_
Get Your Free Sample Now - Explore Exclusive Market Insights:_x000D_
https://www.thebusinessresearchcompany.com/sample.aspx?id=16116&type=smp_x000D_
_x000D_
Which Businesses Are at the Forefront of Mesenchymal Stem Cells Market Development?_x000D_
Major companies operating in the mesenchymal stem cells market are Thermo Fischer Scientific Inc., Danaher Corporation, Merck KgaA, Becton, Dickinson, and Company, Fujifilm Holdings Corporation, Corning Inc., Daiichi Sankyo, Lonza Group, Terumo Corporation, Sartorius AG, Getinge AB, Bio-Rad Laboratories, Eppendorf AG, Bio-Techne Corporation, STEMCELL Technologies Inc., Miltenyi Biotec GmBH, Takara Bio Group, Organogenesis Holdings Inc., Vericel Corporation, HiMedia Laboratories, PromoCell GmbH, CellGenix GmBH, Anterogen Co. Ltd., Pluristem Therapeutics Inc., American Cryostem Corporation_x000D_
_x000D_
What Are the Latest Innovations in the Mesenchymal Stem Cells Market?_x000D_
Leaders in the mesenchymal stem cells (MSCs) market are harnessing advanced technologies, like GMP-compliant isolation, to solidify their market presence. Essentially, GMP (Good Manufacturing Practice) compliant isolation involves the isolation of cells, including MSCs, in compliance with GMP standards to maintain consistent production and monitor product quality. For instance, in July 2023, a Germany-based biotech company, PromoCell, declared the introduction of PromoExQ MSC Growth Medium XF. This medium, free of serum and xeno, is specially designed for the development of human mesenchymal stem cells (MSCs) in an environment regulated by Good Manufacturing Practice (GMP). Adhering to the highest possible quality benchmarks, this medium is endorsed by the EXCiPACT GMP certification scheme, guaranteeing uniform growth and sustenance of MSCs derived from various resources like bone marrow, the umbilical cord matrix, and adipose tissue._x000D_
_x000D_
How Is the Mesenchymal Stem Cells Market Segmented?_x000D_
The mesenchymal stem cells market covered in this report is segmented -_x000D_
_x000D_
1) By Type: Autologous, Allogeneic_x000D_
2) By Product Type: Cells And Cell Lines, Kits, Media And Reagents, Other Product Types_x000D_
3) By Workflow Type: Cell Sourcing And Isolation, Culture And Cryopreservation, Differentiation, Characterization_x000D_
4) By Indication: Bone And Cartilage Repair, Cardiovascular Diseases, Inflammatory And Immunological Diseases, Liver Diseases, Cancer, GvHD, Other Indications_x000D_
5) By Application: Disease Modeling, Drug Development And Discovery, Stem Cell Banking, Tissue Engineering, Toxicology Studies, Other Applications_x000D_
_x000D_
Subsegments:_x000D_
1) By Autologous: Bone Marrow-Derived, Adipose Tissue-Derived, Cord Blood-Derived, Peripheral Blood-Derived_x000D_
2) By Allogeneic: Bone Marrow-Derived, Umbilical Cord-Derived, Placental-Derived, Induced Pluripotent Stem Cells (iPSCs) Derived, Wharton's Jelly-Derived_x000D_
_x000D_
_x000D_
_x000D_
Pre-Book Your Report Now For A Swift Delivery:_x000D_
https://www.thebusinessresearchcompany.com/report/mesenchymal-stem-cells-global-market-report_x000D_
_x000D_
Where Is the Mesenchymal Stem Cells Market Growth Most Prominent?_x000D_
North America was the largest region in the mesenchymal stem cells market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the mesenchymal stem cells market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_
_x000D_
What Is Covered In The Mesenchymal Stem Cells Global Market Report?_x000D_
_x000D_
- Market Size Analysis: Analyze the Mesenchymal Stem Cells Market size by key regions, countries, product types, and applications._x000D_
- Market Segmentation Analysis: Identify various subsegments within the Mesenchymal Stem Cells Market for effective categorization._x000D_
- Key Player Focus: Focus on key players to define their market value, share, and competitive landscape._x000D_
- Growth Trends Analysis: Examine individual growth trends and prospects in the Market._x000D_
- Market Contribution: Evaluate contributions of different segments to the overall Mesenchymal Stem Cells Market growth._x000D_
- Growth Drivers: Detail key factors influencing market growth, including opportunities and drivers._x000D_
- Industry Challenges: Analyze challenges and risks affecting the Mesenchymal Stem Cells Market._x000D_
- Competitive Developments: Analyze competitive developments, such as expansions, agreements, and new product launches in the market._x000D_
_x000D_
Unlock Exclusive Market Insights - Purchase Your Research Report Now!_x000D_
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=16116_x000D_
_x000D_

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.